11065

    537291

    NATHBIOGEN

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    NATH BIO-GENES (I) LTD Share Price Today

    NATH BIO-GENES (I) LTD is currently trading at ₹160, down by ₹1.38 from the previous close. The stock touched an intraday high of ₹164.75 and a low of ₹158.90 during the latest trading session. Over the past one year, NATH BIO-GENES (I) LTD has delivered a loss of 11.25%, while the stock has declined 2.05% in the last one month.

    NATH BIO-GENES (I) LTD performance

    Today’s low Today’s high
    ₹ 158.90 ₹ 164.75
    ₹ 159.18
    52 week low 52 week high
    ₹ 126.15 ₹ 204.00
    ₹ 159.18
    Open Price ₹ 162.50
    Prev. Close ₹ 161.39
    Volume (Shares) 11819.00
    Total traded value ₹ 18.81
    Upper Circuit ₹ 193.66
    Lower Circuit ₹ 129.12
    info

    Investment Returns

    Over 1 Month -2.05% Over 3 Months -17.66% Over 6 Months 9.15% Over 1 Year -11.25%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    NATH BIO-GENES (I) LTD fundamentals


    • Market cap (Cr) 302.50
    • P/E Ratio (TTM) 6.42
    • Beta 0.89
    • Book Value / share 362.75
    • Return on equity 6.69%
    • EPS (TTM) 22.92
    • Dividend yield 1.24%
    • Net profit/quarter (Cr) 32.66
    info icon alternate text
    • Market cap (Cr) 302.40
    • P/E Ratio (TTM) 6.42
    • Beta 0.73
    • Book Value / share 362.75
    • Return on equity 6.69%
    • EPS (TTM) 22.92
    • Dividend yield 1.24%
    • Net profit/quarter (Cr) 32.66
    info icon alternate text

    NATH BIO-GENES (I) LTD Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 322.84
    Operating Expense 292.56
    Net Profit 32.66
    Net Profit Margin (%) 10.11
    Earnings Per Share (EPS) 17.18
    EBITDA 38.18
    Effective Tax Rate (%) 2.15
    Particulars MAR 2026 (Values in Cr)
    Revenue 45.69
    Operating Expense 43.04
    Net Profit 3.79
    Net Profit Margin (%) 8.29
    Earnings Per Share (EPS) 1.99
    EBITDA 10.25
    Effective Tax Rate (%) 39.74
    Particulars DEC 2025 (Values in Cr)
    Revenue 65.96
    Operating Expense 62.28
    Net Profit 7.23
    Net Profit Margin (%) 10.96
    Earnings Per Share (EPS) 3.85
    EBITDA 13.26
    Effective Tax Rate (%) 10.74
    Particulars SEP 2025 (Values in Cr)
    Revenue 39.77
    Operating Expense 36.86
    Net Profit 4.20
    Net Profit Margin (%) 10.56
    Earnings Per Share (EPS) 2.21
    EBITDA 9.12
    Effective Tax Rate (%) 13.22
    Particulars JUN 2025 (Values in Cr)
    Revenue 280.17
    Operating Expense 254.13
    Net Profit 29.21
    Net Profit Margin (%) 10.42
    Earnings Per Share (EPS) 15.37
    EBITDA 33.73
    Effective Tax Rate (%) 2.20
    Particulars MAR 2026 (Values in Cr)
    Revenue 431.60
    Operating Expense 396.32
    Net Profit 44.43
    Net Profit Margin (%) 10.29
    Earnings Per Share (EPS) 23.38
    EBITDA 66.36
    Effective Tax Rate (%) 9.51
    Particulars MAR 2025 (Values in Cr)
    Revenue 362.31
    Operating Expense 323.45
    Net Profit 42.14
    Net Profit Margin (%) 11.63
    Earnings Per Share (EPS) 22.00
    EBITDA 57.55
    Effective Tax Rate (%) 4.48
    Particulars MAR 2024 (Values in Cr)
    Revenue 332.62
    Operating Expense 294.60
    Net Profit 40.18
    Net Profit Margin (%) 12.07
    Earnings Per Share (EPS) 21.63
    EBITDA 51.03
    Effective Tax Rate (%) 5.04
    Particulars MAR 2023 (Values in Cr)
    Revenue 301.29
    Operating Expense 265.53
    Net Profit 35.17
    Net Profit Margin (%) 11.67
    Earnings Per Share (EPS) 18.50
    EBITDA 49.44
    Effective Tax Rate (%) 3.16
    Particulars MAR 2022 (Values in Cr)
    Revenue 278.36
    Operating Expense 254.64
    Net Profit -67.17
    Net Profit Margin (%) -24.13
    Earnings Per Share (EPS) -35.43
    EBITDA -49.53
    Effective Tax Rate (%) -6.24
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 339.08
    ROE % 6.15
    ROCE % 6.86
    Total Debt to Total Equity 0.19
    EBITDA Margin 15.09
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 320.94
    ROE % 6.70
    ROCE % 7.23
    Total Debt to Total Equity 0.18
    EBITDA Margin 16.24
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 301.61
    ROE % 6.28
    ROCE % 7.03
    Total Debt to Total Equity 0.18
    EBITDA Margin 16.39
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 285.16
    ROE % 4.38
    ROCE % 5.64
    Total Debt to Total Equity 0.17
    EBITDA Margin 14.04
    Particulars MAR 2013 (Values in Cr)
    Book Value / Share 35.91
    ROE % 22.77
    ROCE % 23.41
    Total Debt to Total Equity 0.29
    EBITDA Margin 14.87
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 341.33
    ROE % 6.69
    ROCE % 7.25
    Total Debt to Total Equity 0.17
    EBITDA Margin 15.92
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 321.33
    ROE % 6.79
    ROCE % 7.31
    Total Debt to Total Equity 0.18
    EBITDA Margin 16.41
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 301.70
    ROE % 6.31
    ROCE % 7.06
    Total Debt to Total Equity 0.18
    EBITDA Margin 16.44
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 285.19
    ROE % 4.12
    ROCE % 5.32
    Total Debt to Total Equity 0.17
    EBITDA Margin 14.05
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 322.71
    ROE % 9.51
    ROCE % 9.74
    Total Debt to Total Equity 0.15
    EBITDA Margin 22.25
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 88.89
    Total Assets 1026.20
    Total Liabilities 1026.20
    Total Equity 644.38
    Share Outstanding 1
    Price to Book Ratio 0.43
    Return on Assets (%) 3.76
    Return on Capital (%) 5.03
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 77.40
    Total Assets 880.23
    Total Liabilities 880.23
    Total Equity 609.91
    Share Outstanding 1
    Price to Book Ratio 0.54
    Return on Assets (%) 4.50
    Return on Capital (%) 5.5
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 37.99
    Total Assets 792.79
    Total Liabilities 792.79
    Total Equity 573.15
    Share Outstanding 1
    Price to Book Ratio 0.47
    Return on Assets (%) 4.41
    Return on Capital (%) 5.16
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 4.18
    Total Assets 739.48
    Total Liabilities 739.48
    Total Equity 541.92
    Share Outstanding 1
    Price to Book Ratio 0.75
    Return on Assets (%) -9.11
    Return on Capital (%) -10.61
    Particulars MAR 2013 (Values in Cr)
    Cash & Short Term Investments 2.48
    Total Assets 158.28
    Total Liabilities 158.28
    Total Equity 57.47
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 7.42
    Return on Capital (%) 15.49
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 87.63
    Total Assets 1016.86
    Total Liabilities 1016.86
    Total Equity 648.66
    Share Outstanding 1
    Price to Book Ratio 0.43
    Return on Assets (%) 4.14
    Return on Capital (%) 5.55
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 75.50
    Total Assets 877.08
    Total Liabilities 877.08
    Total Equity 610.65
    Share Outstanding 1
    Price to Book Ratio 0.54
    Return on Assets (%) 4.58
    Return on Capital (%) 5.59
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 37.98
    Total Assets 792.97
    Total Liabilities 792.97
    Total Equity 573.35
    Share Outstanding 1
    Price to Book Ratio 0.47
    Return on Assets (%) 4.43
    Return on Capital (%) 5.18
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 4.16
    Total Assets 739.53
    Total Liabilities 739.53
    Total Equity 541.96
    Share Outstanding 1
    Price to Book Ratio 0.75
    Return on Assets (%) -9.10
    Return on Capital (%) -10.61
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 29.21
    Total Assets 789.50
    Total Liabilities 789.50
    Total Equity 613.27
    Share Outstanding 1
    Price to Book Ratio 0.93
    Return on Assets (%) 7.05
    Return on Capital (%) 7.86
    Particulars MAR 2025 (Values in Cr)
    Net Income 40.58
    Cash from Operations 18.66
    Cash from Investing -3.96
    Cash from Financing -2.12
    Net change in Cash 11.48
    Free Cash Flow 26.58
    Particulars MAR 2024 (Values in Cr)
    Net Income 41.56
    Cash from Operations 74.93
    Cash from Investing -27.40
    Cash from Financing -7.77
    Net change in Cash 39.41
    Free Cash Flow 101.70
    Particulars MAR 2023 (Values in Cr)
    Net Income 36.16
    Cash from Operations 39.28
    Cash from Investing -2.88
    Cash from Financing -1.66
    Net change in Cash 33.81
    Free Cash Flow 41.76
    Particulars MAR 2022 (Values in Cr)
    Net Income -63.43
    Cash from Operations 19.92
    Cash from Investing -19.85
    Cash from Financing -22.23
    Net change in Cash -25.03
    Free Cash Flow 21.02
    Particulars MAR 2013 (Values in Cr)
    Net Income 12.29
    Cash from Operations 14.76
    Cash from Investing -20.76
    Cash from Financing 5.74
    Net change in Cash -0.81
    Free Cash Flow 36.11
    Particulars MAR 2025 (Values in Cr)
    Net Income 44.12
    Cash from Operations 27.88
    Cash from Investing -4.05
    Cash from Financing -10.62
    Net change in Cash 12.12
    Free Cash Flow 35.63
    Particulars MAR 2024 (Values in Cr)
    Net Income 42.12
    Cash from Operations 75.06
    Cash from Investing -27.39
    Cash from Financing -9.80
    Net change in Cash 37.51
    Free Cash Flow 101.83
    Particulars MAR 2023 (Values in Cr)
    Net Income 36.31
    Cash from Operations 39.28
    Cash from Investing -2.88
    Cash from Financing -1.66
    Net change in Cash 33.81
    Free Cash Flow 41.76
    Particulars MAR 2022 (Values in Cr)
    Net Income -63.38
    Cash from Operations 19.92
    Cash from Investing -19.86
    Cash from Financing -22.23
    Net change in Cash -25.04
    Free Cash Flow 21.03
    Particulars MAR 2021 (Values in Cr)
    Net Income 56.75
    Cash from Operations 1.41
    Cash from Investing -10.28
    Cash from Financing 16.40
    Net change in Cash 7.23
    Free Cash Flow 12.96
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    BRITANNIA INDUSTRIES LTD 5521.55 52.52 26.04 132996.63 5038.00 6336.95
    NESTLE INDIA LTD. 1520.50 79.11 56.85 293200.19 1085.00 1532.50
    FOODS & INNS LTD. 54.16 14.37 0.70 398.25 45.00 112.00
    HINDUSTAN UNILEVER LTD. 2108.05 44.92 10.16 495305.59 2019.00 2734.31
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    BRITANNIA INDUSTRIES LTD 5521.55 51.94 28.65 132996.63 5038.00 6336.95
    COLGATE PALMOLIVE LTD. 2084.90 41.42 35.79 56706.28 1781.60 2505.00
    NESTLE INDIA LTD. 1520.50 78.09 55.22 293200.19 1085.00 1532.50
    FOODS & INNS LTD. 54.16 12.71 0.69 398.25 45.00 112.00

    NATH BIO-GENES (I) LTD shareholding pattern

    Holding
    54.12%
    45.59%
    0.26%
    0.01%
    13.78%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    NATH BIO-GENES (I) LTD Technicals Summary

    159.18 -1.36 redarrow
    red-green-graph indicator
    15 Bearish
    1 Bullish
    • 5 Days 161.60
    • 26 Days 163.30
    • 10 Days 161.80
    • 50 Days 164.20
    • 12 Days 162.00
    • 100 Days 163.10
    • 20 Days 162.80
    • 200 Days 163.90
    163.90 PIVOT
    First Support 157.89 First Resistance 167.39 Second Support 154.40 Second Resistance 173.40 Third Support 148.39 Third Resistance 176.89
    RSI 47.18 ADX 23.96 MACD -1.37 Williams % R -45.80 Commodity Channel Index (CCI) 20.44
    Date 2026-07-30 Week 16520.00 Same Day 43786.00 Month 8992.00
    1 Year 0.90 3 Year 1.04
    Over 1 Month
    -2.05% down
    Over 1 Year
    -11.25% down
    Over 3 Months
    -17.66% down
    Over 3 Years
    -8.15% down
    Over 6 Months
    9.15% down
    Over 5 Years
    -15.09% down

    NATH BIO-GENES (I) LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    14 Aug 2025 2.0 Final 14 Aug 2025 Equity shares
    09 Aug 2024 2.0 Final 09 Aug 2024 Equity shares
    04 Jul 2023 2.0 Final 30 Jun 2023 Equity shares
    23 Jun 2022 2.0 Final 25 Jun 2022 Equity shares
    18 Aug 2021 2.0 Final 22 Aug 2021 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    14 Aug 2025 2.0 Final 14 Aug 2025 Equity shares
    09 Aug 2024 2.0 Final 09 Aug 2024 Equity shares
    04 Jul 2023 2.0 Final 30 Jun 2023 Equity shares
    23 Jun 2022 2.0 Final 25 Jun 2022 Equity shares
    18 Aug 2021 2.0 Final 22 Aug 2021 Equity shares

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Nath Bio-Genes (India) Ltd?

    Answer Field

    Nath Bio-Genes (India) Ltd share price is for NSE ₹ 160.00 & for BSE ₹ 160.65 as on Jul 31 2026 03:29 PM.

    What is the Market Cap of Nath Bio-Genes (India) Ltd Share?

    Answer Field

    The market cap of Nath Bio-Genes (India) Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 31 2026 03:29 PM.

    What is the 52 Week High and Low of Nath Bio-Genes (India) Ltd?

    Answer Field

    The 52 Week High and Low of Nath Bio-Genes (India) Ltd for NSE is ₹ 204.00 and ₹ 126.15 and for BSE is ₹ 207.00 and ₹ 126.75.

    What is 1 year return for Nath Bio-Genes (India) Ltd?

    Answer Field

    The 1 year returns on the stock has been -11.25%.

    What is the P/E Ratio of Nath Bio-Genes (India) Ltd Share?

    Answer Field

    As on Jul 31 2026 03:29 PM the price-to-earnings (PE) ratio for Nath Bio-Genes (India) Ltd share is 6.42.

    What is the PB ratio of Nath Bio-Genes (India) Ltd Share?

    Answer Field

    As on Jul 31 2026 03:29 PM, the price-to-book (PB) ratio for Nath Bio-Genes (India) Ltd share is 362.75.

    How to Buy Nath Bio-Genes (India) Ltd Share?

    Answer Field

    You can trade in Nath Bio-Genes (India) Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Nath Bio-Genes (India) Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Nath Bio-Genes (India) Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Nath Bio-Genes (India) Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |